TY - JOUR
T1 - Description and functional validation of human enteroendocrine cell sensors
AU - Beumer, Joep
AU - Geurts, Maarten H.
AU - Geurts, Veerle
AU - Andersson-Rolf, Amanda
AU - Akkerman, Ninouk
AU - Völlmy, Franziska
AU - Krueger, Daniel
AU - Busslinger, Georg A.
AU - Martínez-Silgado, Adriana
AU - Boot, Charelle
AU - Yousef Yengej, Fjodor A.
AU - Puschhof, Jens
AU - Van de Wetering, Wiline J.
AU - Knoops, Kevin
AU - López-Iglesias, Carmen
AU - Peters, Peter J.
AU - Vivié, Judith A.
AU - Mooijman, Dylan
AU - van Es, Johan H.
AU - Clevers, Hans
N1 - Publisher Copyright:
© 2024 the authors.
PY - 2024/10/18
Y1 - 2024/10/18
N2 - Enteroendocrine cells (EECs) are gut epithelial cells that respond to intestinal contents by secreting hormones, including the incretins glucagon-like peptide 1 (GLP-1) and gastric inhibitory protein (GIP), which regulate multiple physiological processes. Hormone release is controlled through metabolite-sensing proteins. Low expression, interspecies differences, and the existence of multiple EEC subtypes have posed challenges to the study of these sensors. We describe differentiation of stomach EECs to complement existing intestinal organoid protocols. CD200 emerged as a pan-EEC surface marker, allowing deep transcriptomic profiling from primary human tissue along the stomach-intestinal tract. We generated loss-of-function mutations in 22 receptors and subjected organoids to ligand-induced secretion experiments. We delineate the role of individual human EEC sensors in the secretion of hormones, including GLP-1. These represent potential pharmacological targets to influence appetite, bowel movement, insulin sensitivity, and mucosal immunity.
AB - Enteroendocrine cells (EECs) are gut epithelial cells that respond to intestinal contents by secreting hormones, including the incretins glucagon-like peptide 1 (GLP-1) and gastric inhibitory protein (GIP), which regulate multiple physiological processes. Hormone release is controlled through metabolite-sensing proteins. Low expression, interspecies differences, and the existence of multiple EEC subtypes have posed challenges to the study of these sensors. We describe differentiation of stomach EECs to complement existing intestinal organoid protocols. CD200 emerged as a pan-EEC surface marker, allowing deep transcriptomic profiling from primary human tissue along the stomach-intestinal tract. We generated loss-of-function mutations in 22 receptors and subjected organoids to ligand-induced secretion experiments. We delineate the role of individual human EEC sensors in the secretion of hormones, including GLP-1. These represent potential pharmacological targets to influence appetite, bowel movement, insulin sensitivity, and mucosal immunity.
UR - http://www.scopus.com/inward/record.url?scp=85206854141&partnerID=8YFLogxK
U2 - 10.1126/science.adl1460
DO - 10.1126/science.adl1460
M3 - Article
C2 - 39418382
AN - SCOPUS:85206854141
SN - 0036-8075
VL - 386
SP - 341
EP - 348
JO - Science
JF - Science
IS - 6719
ER -